Generalized Eruptive Histiocytosis Associated With FIP1L1-PDGFRA–Positive Chronic Eosinophilic Leukemia
- Autores: Birgit Ziegler, Wiebke K. Peitsch, Andreas Reiter, Alexander Marx, Sergij Goerdt, Cyrill Géraud
- Localización: JAMA Dermatology, ISSN 2168-6068, Vol. 151, Nº. 7, 2015, págs. 766-769
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
Importance Generalized eruptive histiocytosis (GEH) is a rare non–Langerhans cell histiocytosis with a benign, self-healing course. Neoplastic hematologic disorders of the myeloid lineage have been reported in association with GEH in 4 patients. A clonal association between GEH and the underlying leukemia was suspected in these patients but could only be confirmed in one patient.
Observations A male patient in his 20s presented with asymptomatic red to brown macules and papules. A skin biopsy confirmed a diagnosis of GEH. His blood cell count revealed hypereosinophilia. Morphologic and molecular analyses from bone marrow and blood samples revealed FIP1L1-PDGFRA–positive chronic eosinophilic leukemia. The patient was treated with imatinib and achieved complete clinical remission of his leukemia and the GEH.
Conclusions and Relevance To our knowledge, this is the first report of a patient with GEH associated with FIP1L1-PDGFRA–positive chronic eosinophilic leukemia. Generalized eruptive histiocytosis in association with a myeloid neoplasm may occur in 2 variants: a reactive condition or a clonal derivative of the underlying leukemia. In this case, both diseases responded well after initiation of treatment with imatinib.
